Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Other Non-Current Liabilities (2018 - 2021)

Cue Biopharma's Other Non-Current Liabilities history spans 4 years, with the latest figure at $89000.0 for Q2 2021.

  • For Q2 2021, Other Non-Current Liabilities changed N/A year-over-year to $89000.0; the TTM value through Jun 2021 reached $89000.0, changed N/A, while the annual FY2020 figure was $1.9 million, 51.78% down from the prior year.
  • Other Non-Current Liabilities for Q2 2021 was $89000.0 at Cue Biopharma, down from $1.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $6.4 million in Q2 2019 and bottomed at $89000.0 in Q2 2021.
  • The 4-year median for Other Non-Current Liabilities is $2.5 million (2020), against an average of $2.9 million.
  • The largest annual shift saw Other Non-Current Liabilities soared 774.37% in 2019 before it crashed 76.78% in 2020.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $5.2 million in 2018, then decreased by 22.36% to $4.0 million in 2019, then plummeted by 51.78% to $1.9 million in 2020, then plummeted by 95.41% to $89000.0 in 2021.
  • Per Business Quant, the three most recent readings for CUE's Other Non-Current Liabilities are $89000.0 (Q2 2021), $1.3 million (Q1 2021), and $1.9 million (Q4 2020).